.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
AstraZeneca
Colorcon
QuintilesIMS
Deloitte
Chubb
Merck
McKesson
Queensland Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 197 56 289

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis UsOFORTAfludarabine phosphateTABLET;ORAL022273-001Dec 18, 2008DISCNNoNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist